NURECA
Back to Cashflow Statement
|
NURECA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3.30 Cr | ₹-19 Cr | ₹-2.71 Cr | ₹10 Cr | ₹1.40 Cr |
What is the latest Cash Flow from Operating Activities ratio of NURECA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3.30 Cr |
| Mar2025 | ₹-19 Cr |
| Mar2024 | ₹-2.71 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹1.40 Cr |
How is Cash Flow from Operating Activities of NURECA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.30 Cr | Positive | |
| Mar2025 | ₹-19 Cr | Negative | |
| Mar2024 | ₹-2.71 Cr | Negative | |
| Mar2023 | ₹10 Cr | 631.02 | |
| Mar2022 | ₹1.40 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NURECA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NURECA | ₹308.8 Cr | -3% | -4.1% | 38.3% | Stock Analytics | |
| LENSKART SOLUTIONS | ₹118,977.0 Cr | 3.3% | 21.1% | NA | Stock Analytics | |
| POLY MEDICURE | ₹17,251.2 Cr | -3.5% | -0.4% | -14.6% | Stock Analytics | |
| 3B BLACKBIO DX | ₹1,257.2 Cr | 1.3% | 21.7% | 4.7% | Stock Analytics | |
| LAXMI DENTAL | ₹1,097.8 Cr | 2.1% | -8.7% | -41.6% | Stock Analytics | |
| PREVEST DENPRO | ₹458.3 Cr | -0.3% | 1% | -30.4% | Stock Analytics | |
NURECA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NURECA | -3% |
-4.1% |
38.3% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses